Article
Hybrid large hepatitis B surface protein composed of two viral genotypes C and D induces strongly cross-neutralizing antibodies.
Vaccine - 13 Oct 2023
Sanada Takahiro, Oda Yasunori, Ohashi Chinatsu, Isotani Kentaro, Goh Yasumasa, Kohara Michinori
Abstract excerpt
Hepatitis B virus (HBV) vaccination is known to effectively decrease the risk of HBV infection. However, several issues need to be addressed in order to develop an improved HBV vaccine. Although the HBV vaccine has been shown to be effective, this vaccine needs to be more efficacious in defined groups, including non-responders (i.e., individuals who do not develop a protective response even after vaccination) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
